Anne Marie Healy
Has grant
Professor (Personal Chair) of Pharmaceutics and Pharmaceutical Technology
Research Interests
Make your next move.
Prepare your application
Review drafts before you send them.
Explore related searches
Recent Grants
Grant: Close
Commercialisation Fund Proof of Concept Award
Open Date: 2023-01-01
Close Date: 2024-01-01
Grant: Open
TCD Panoz Pharmaceutical Innovation PhD Scholarship
Open Date: 2023-01-01
Close Date: 2027-01-01
Grant: Open
EPSRC-SFI Centre for Doctoral Training (CDT) Partnership Programme
Open Date: 2019-01-01
Close Date: 2027-01-01
Grant: Close
SSPC Pharmaceutical Research Centre Phase 2
Open Date: 2019-01-01
Close Date: 2025-01-01
Grant: Close
IRC/APC Ltd. Employment Based PhD Programme
Open Date: 2018-01-01
Close Date: 2022-01-01
Articles (15)
Year:
2026
Year:
2025
Year:
2025
Year:
2024
Year:
2023
Several studies have demonstrated the feasibility of in situ co-crystallization in different pharmaceutical processes such as spray drying, hot melt extrusion, and fluidized bed granulation (FBG) to produce co-crystal-in-excipient formulations. However, no previous studies have examined such a one step in situ co-crystallization process for co-crystal formulations where the coformer is a polymer. In the current study, we explored the use of FBG to produce co-crystal granules of dapsone (DAP) and different molecular weight polyethylene glycols (PEGs). Solvent evaporation (SE) was proven to generate DAP-PEGs co-crystals at a particular weight ratio of 55:45 w/w between DAP and PEG, which was subsequently used in FBG, using microcrystalline cellulose and hydroxypropyl methyl cellulose as filler excipient and binder, respectively. FBG could generate co-crystals with higher purity than SE. Granules containing DAP-PEG 400 co-crystal could be prepared without any additional binder. DAP-PEG co-crystal granules produced by FBG demonstrated superior pharmaceutical properties, including flow properties and tableting properties, compared to DAP and DAP-PEG co-crystals prepared by SE. Overall, in situ co-crystallization via FBG can effectively produce API-polymer co-crystals and enhance the pharmaceutical properties.
Year:
2023
Year:
2023
Year:
2023
Year:
2023
Year:
2023
Year:
2022
Year:
2021
Year:
2021
Year:
2020
Year:
2020
Collaborators (12)
Gavin P Andrews
Professor
The Queen's University Belfast
Peter O Connell
Trinity College Dublin
Raquel Fernández-García
Assistant Professor
Universidad Complutense de Madrid
Simon E. Lawrence
University College Cork
Abina Crean
Professor of Pharmaceutics
University College Cork
Steven Ferguson
Dublin City University
Fiona McCartney
University College Dublin
Timothy M. Korter
Syracuse University
Dolores Remedios Serrano
Assitant Professor - Profesor Ayudante Doctor
Universidad Complutense de Madrid
Luke M. Geever
Technological University of the Shannon
David Brayden
Professor of Advanced Drug Delivery
Dublin City University
Aikaterini Lalatsa
University Of Strathclyde
Make your next move.
Prepare your application
Review drafts before you send them.